We have extensive expertise in iPSCs – especially clonal cell line derivation, process and protocol development, QC, characterisation and banking. We also have a semi-automated platform for clonal cell line derivation that allows the generation of high numbers of clonal cell lines which enables the... Read more
This company has no offices yet